| Title | Journal of Cardiovascular Pharmacology and Therapeutics |
| Abbreviation | J. Cardiovasc. Pharmacol. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2) |
| h-index | 57 |
| Overall Rank/Ranking | 7531 |
| SCImago Journal Rank (SJR) | 0.696 |
| Impact Score | 2.60 |
| Publisher | SAGE Publications Ltd |
| Country | United Kingdom |
| ISSN | 10742484, 19404034 |
| Best Quartile | Q2 |
| Coverage History | 1996-2023 |
Journal of Cardiovascular Pharmacology and Therapeutics is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2). It is published by SAGE Publications Ltd. The overall rank of Journal of Cardiovascular Pharmacology and Therapeutics is 7531. According to SCImago Journal Rank (SJR), this journal is ranked 0.696. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 57. The best quartile for this journal is Q2.
The ISSN of Journal of Cardiovascular Pharmacology and Therapeutics journal is 10742484, 19404034. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Cardiovascular Pharmacology and Therapeutics is cited by a total of 433 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of Cardiovascular Pharmacology and Therapeutics is 2.60, which is computed in 2024 as per its definition. Journal of Cardiovascular Pharmacology and Therapeutics IF is increased by a factor of 0.02 and approximate percentage change is 0.78% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of Cardiovascular Pharmacology and Therapeutics is 2.60. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.60 |
| 2022 | 2.58 |
| 2021 | 2.43 |
| 2020 | 2.09 |
| 2019 | 2.17 |
| 2018 | 2.33 |
| 2017 | 2.61 |
| 2016 | 2.95 |
| 2015 | 3.10 |
| 2014 | 2.55 |
Journal of Cardiovascular Pharmacology and Therapeutics has an h-index of 57. It means 57 articles of this journal have more than 57 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Cardiovascular Pharmacology and Therapeutics is 10742484, 19404034. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Cardiovascular Pharmacology and Therapeutics is 7531. According to SCImago Journal Rank (SJR), this journal is ranked 0.696. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.696 |
| 2022 | 0.650 |
| 2021 | 0.685 |
| 2020 | 0.787 |
| 2019 | 0.674 |
| 2018 | 0.877 |
| 2017 | 1.272 |
| 2016 | 1.127 |
| 2015 | 1.110 |
| 2014 | 1.061 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 7531 |
| 2022 | 7826 |
| 2021 | 7060 |
| 2020 | 6147 |
| 2019 | 7244 |
| 2018 | 5235 |
| 2017 | 3028 |
| 2016 | 3681 |
| 2015 | 3819 |
| 2014 | 3972 |
Journal of Cardiovascular Pharmacology and Therapeutics is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1996-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Cardiovascular Pharmacology and Therapeutics is J. Cardiovasc. Pharmacol. Ther.. This abbreviation ('J. Cardiovasc. Pharmacol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Cardiovascular Pharmacology and Therapeutics latest impact IF is 2.60. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.10 (2015) and 2.09 (2020), respectively, in the last 10 years. Moreover, its average IS is 2.54 in the previous 10 years.
The Journal of Cardiovascular Pharmacology and Therapeutics has an SJR (SCImago Journal Rank) of 0.696, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.272 in 2017 and the lowest being 0.650 in 2022. Furthermore, the average SJR of the Journal of Cardiovascular Pharmacology and Therapeutics over the previous 10-year period stands at 2.54.
The latest h-index of the Journal of Cardiovascular Pharmacology and Therapeutics is 57.
The Journal of Cardiovascular Pharmacology and Therapeutics is published by the SAGE Publications Ltd, with its country of publication being the United Kingdom.
The Journal of Cardiovascular Pharmacology and Therapeutics is currently ranked 7531 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3028 in 2017 and its lowest position of 7826 in 2022.
The standard ISO4 abbreviation for the Journal of Cardiovascular Pharmacology and Therapeutics is J. Cardiovasc. Pharmacol. Ther..
Journal of Cardiovascular Pharmacology and Therapeutics is classified as a journal that the SAGE Publications Ltd publishes.
The Journal of Cardiovascular Pharmacology and Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Cardiovascular Pharmacology and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 10742484, 19404034.
The best quartile for the Journal of Cardiovascular Pharmacology and Therapeutics is Q2 (2023).
The Journal of Cardiovascular Pharmacology and Therapeutics coverage history can be summarized as follows: 1996-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Journal of Supply Chain Management | journal | 587 | Wiley-Blackwell | 112 | 12.51 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| Mathematical Modelling and Analysis | journal | 11193 | Vilnius Gediminas Technical University | 29 | 1.75 |
| Journal of Classical Sociology | journal | 15798 | SAGE Publications Ltd | 30 | 1.30 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 27272 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Canadian Journal of Mathematics | journal | 9072 | Canadian Mathematical Society | 45 | 0.78 |
| International Journal of Press/Politics | journal | 711 | SAGE Publications Inc. | 81 | 7.76 |
| Clinical Interventions in Aging | journal | 5314 | Dove Medical Press Ltd. | 104 | 3.55 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.60 |
| 2022 | 2.58 |
| 2021 | 2.43 |
| 2020 | 2.09 |
| 2019 | 2.17 |
| 2018 | 2.33 |
| 2017 | 2.61 |
| 2016 | 2.95 |
| 2015 | 3.10 |
| 2014 | 2.55 |
